Scandion Oncology appoints Johnny Stilou as new CFO
Scandion Oncology A/S today announces that Johnny Stilou has been appointed as the company’s new CFO, and joins the company, effective no later than August 1, 2021. He has a long experience from both Danish and international listed companies – most recently Nuevolution AB and Amgen Inc. Johnny Stilou succeeds Carit Jacques Andersen, who wishes to pursue a career outside Scandion Oncology.Johnny Stilou’s strong financial background includes positions as CFO of Nuevolution AB (acquired by Amgen Inc.) and EVP & CFO of Veloxis Pharmaceuticals. Johnny has a successful track record of leading